These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9427299

  • 21. [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.
    Xu J, Hassanzadeh B, Chu W, Tu Z, Jones LA, Luedtke RR, Perlmutter JS, Mintun MA, Mach RH.
    Synapse; 2010 Jun; 64(6):449-59. PubMed ID: 20175227
    [Abstract] [Full Text] [Related]

  • 22. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
    Luedtke RR, Freeman RA, Boundy VA, Martin MW, Huang Y, Mach RH.
    Synapse; 2000 Dec 15; 38(4):438-49. PubMed ID: 11044891
    [Abstract] [Full Text] [Related]

  • 23. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
    Kula NS, Tarazi FI, Baldessarini RJ, Xu L, Bakthavachalam V, Pounds S, True CD.
    Eur J Pharmacol; 1999 Feb 12; 367(1):139-42. PubMed ID: 10082277
    [Abstract] [Full Text] [Related]

  • 24. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 12; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 25. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
    Zhang MR, Haradahira T, Maeda J, Okauchi T, Kawabe K, Noguchi J, Kida T, Suzuki K, Suhara T.
    Nucl Med Biol; 2002 Feb 12; 29(2):233-41. PubMed ID: 11823129
    [Abstract] [Full Text] [Related]

  • 26. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
    Rogoz R, Dziedzicka-Wasylewska M.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar 12; 359(3):178-86. PubMed ID: 10208304
    [Abstract] [Full Text] [Related]

  • 27. Selective alkylatation of dopamine D2 and D4 receptors in rat brain by N-(p-isothiocyanatophenethyl)spiperone.
    Zhang K, Tarazi FI, Kula NS, Baldessarini RJ, Neumeyer JL.
    Neurosci Lett; 1999 Oct 29; 274(3):155-8. PubMed ID: 10548413
    [Abstract] [Full Text] [Related]

  • 28. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.
    Murray AM, Ryoo HL, Gurevich E, Joyce JN.
    Proc Natl Acad Sci U S A; 1994 Nov 08; 91(23):11271-5. PubMed ID: 7972046
    [Abstract] [Full Text] [Related]

  • 29. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ.
    Brain Res; 2001 Nov 30; 920(1-2):41-54. PubMed ID: 11716810
    [Abstract] [Full Text] [Related]

  • 30. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY.
    Brain Res; 1995 May 29; 681(1-2):109-16. PubMed ID: 7552267
    [Abstract] [Full Text] [Related]

  • 31. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain.
    Khan ZU, Gutiérrez A, Martín R, Peñafiel A, Rivera A, De La Calle A.
    J Comp Neurol; 1998 Dec 21; 402(3):353-71. PubMed ID: 9853904
    [Abstract] [Full Text] [Related]

  • 32. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
    Vile JM, D'Souza UM, Strange PG.
    J Neurochem; 1995 Feb 21; 64(2):940-3. PubMed ID: 7830089
    [Abstract] [Full Text] [Related]

  • 33. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW, Helmeste DM, Fang H, Li M, Vu R, Bunney W, Potkin S, Jones EG.
    Brain Res; 1997 Aug 08; 765(1):7-12. PubMed ID: 9310388
    [Abstract] [Full Text] [Related]

  • 34. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
    Lahti RA, Roberts RC, Cochrane EV, Primus RJ, Gallager DW, Conley RR, Tamminga CA.
    Mol Psychiatry; 1998 Nov 08; 3(6):528-33. PubMed ID: 9857979
    [Abstract] [Full Text] [Related]

  • 35. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN.
    Arch Gen Psychiatry; 1997 Mar 08; 54(3):225-32. PubMed ID: 9075463
    [Abstract] [Full Text] [Related]

  • 36. Effects of YM-43611, a novel dopamine D2-like receptor antagonist, on immediate early gene expression in the rat forebrain.
    Kurokawa K, Narita M, Koshiya K, Hidaka K, Ohmori J, Satoh K.
    Neuropsychopharmacology; 1997 Jul 08; 17(1):27-33. PubMed ID: 9194047
    [Abstract] [Full Text] [Related]

  • 37. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, Curtis NR, Kulagowski JJ, Freedman SB.
    Mol Pharmacol; 1996 Dec 08; 50(6):1658-64. PubMed ID: 8967990
    [Abstract] [Full Text] [Related]

  • 38. Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats.
    Schoots O, Seeman P, Guan HC, Paterson AD, Van Tol HH.
    Eur J Pharmacol; 1995 Mar 15; 289(1):67-72. PubMed ID: 7781713
    [Abstract] [Full Text] [Related]

  • 39. Brain sigma receptors labelled by [3H]nemonapride.
    Helmeste D, Tang SW, Fang H, Li M.
    Eur J Pharmacol; 1996 Apr 22; 301(1-3):R1-3. PubMed ID: 8773467
    [Abstract] [Full Text] [Related]

  • 40. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep 22; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.